Human Molecular Genetics, 2000, Vol. 9, No. 2 275-282
© 2000 Oxford University Press
Clinical, biochemical and molecular genetic correlations in Friedreichs ataxia
1University Department of Clinical Neurosciences, Royal Free and University College Medical School, London, UK, 2Department of Human Genetics, Imperial College of Medicine at St Marys, London, UK and 3Institute of Neurology, University College London, London, UK
Friedreichs ataxia (FRDA) is an autosomal recessive disorder with a frequency of 1 in 50 000 live births. In 97% of patients it is caused by the abnormal expansion of a GAA repeat in intron 1 of the FRDA gene on chromosome 9, which encodes a 210 amino acid protein called frataxin. Frataxin is widely expressed and has been localized to mitochondria although its function is unknown. We have investigated mitochondrial function, mitochondrial DNA levels, aconitase activity and iron content in tissues from FRDA patients. There were significant reductions in the activities of complex I, complex II/III and aconitase in FRDA heart. Respiratory chain and aconitase activities were decreased although not significantly in skeletal muscle, but were normal in FRDA cerebellum and dorsal root ganglia, although there was a mild decrease in aconitase activity in the latter. Mitochondrial DNA levels were reduced in FRDA heart and skeletal muscle, although in skeletal muscle this was paralleled by a decline in citrate synthase activity. Increased iron deposition was seen in FRDA heart, liver and spleen in a pattern consistent with a mitochondrial location. The iron accumulation, mitochondrial respiratory chain and aconitase dysfunction and mitochondrial DNA depletion in FRDA heart samples largely paralleled those in the yeast YFH1 knockout model, suggesting that frataxin may be involved in mitochondrial iron regulation or iron sulphur centre synthesis. However, the severe deficiency in aconitase activity also suggests that oxidant stress may induce a self-amplifying cycle of oxidative damage and mitochondrial dysfunction, which may contribute to cellular toxicity.
+ To whom correspondence should be addressed at: University Department of Clinical Neurosciences, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK. Tel: +44 171 830 2012; Fax: +44 171 431 1577; Email: schapira@fhsm.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Leidgens, S. De Smet, and F. Foury Frataxin interacts with Isu1 through a conserved tryptophan in its {beta}-sheet Hum. Mol. Genet., November 11, 2009; (2009) ddp495v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Castaldo, M Pinelli, A Monticelli, F Acquaviva, M Giacchetti, A Filla, S Sacchetti, S Keller, V E Avvedimento, L Chiariotti, et al. DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients J. Med. Genet., December 1, 2008; 45(12): 808 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
F M Skidmore, V Drago, P Foster, I M Schmalfuss, K M Heilman, and R R Streiff Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 467 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Condo, N. Ventura, F. Malisan, A. Rufini, B. Tomassini, and R. Testi In vivo maturation of human frataxin Hum. Mol. Genet., July 1, 2007; 16(13): 1534 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ribai, F. Pousset, M.-L. Tanguy, S. Rivaud-Pechoux, I. Le Ber, F. Gasparini, P. Charles, A.-S. Beraud, M. Schmitt, M. Koenig, et al. Neurological, Cardiological, and Oculomotor Progression in 104 Patients With Friedreich Ataxia During Long-term Follow-up Arch Neurol, April 1, 2007; 64(4): 558 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Llorens, J. A. Navarro, M. J. Martinez-Sebastian, M. K. Baylies, S. Schneuwly, J. A. Botella, and M. D. Molto Causative role of oxidative stress in a Drosophila model of Friedreich ataxia FASEB J, February 1, 2007; 21(2): 333 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nikali, A. Suomalainen, J. Saharinen, M. Kuokkanen, J. N. Spelbrink, T. Lonnqvist, and L. Peltonen Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky Hum. Mol. Genet., October 15, 2005; 14(20): 2981 - 2990. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sturm, U. Bistrich, M. Schranzhofer, J. P. Sarsero, U. Rauen, B. Scheiber-Mojdehkar, H. de Groot, P. Ioannou, and F. Petrat Friedreich's Ataxia, No Changes in Mitochondrial Labile Iron in Human Lymphoblasts and Fibroblasts: A DECREASE IN ANTIOXIDATIVE CAPACITY? J. Biol. Chem., February 25, 2005; 280(8): 6701 - 6708. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. J. Chen, X. Wang, B. A. Kaufman, and R. A. Butow Aconitase Couples Metabolic Regulation to Mitochondrial DNA Maintenance Science, February 4, 2005; 307(5710): 714 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lange, U. Muhlenhoff, M. Denzel, G. Kispal, and R. Lill The Heme Synthesis Defect of Mutants Impaired in Mitochondrial Iron-Sulfur Protein Biogenesis Is Caused by Reversible Inhibition of Ferrochelatase J. Biol. Chem., July 9, 2004; 279(28): 29101 - 29108. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Wilkinson, A. H. Crosby, C. Turner, L. J. Bradley, L. Ginsberg, N. W. Wood, A. H. Schapira, and T. T. Warner A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia Brain, May 1, 2004; 127(5): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Simon, H. Seznec, A. Gansmuller, N. Carelle, P. Weber, D. Metzger, P. Rustin, M. Koenig, and H. Puccio Friedreich Ataxia Mouse Models with Progressive Cerebellar and Sensory Ataxia Reveal Autophagic Neurodegeneration in Dorsal Root Ganglia J. Neurosci., February 25, 2004; 24(8): 1987 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Karthikeyan, J. H. Santos, M. A. Graziewicz, W. C. Copeland, G. Isaya, B. V. Houten, and M. A. Resnick Reduction in frataxin causes progressive accumulation of mitochondrial damage Hum. Mol. Genet., December 15, 2003; 12(24): 3331 - 3342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Crisp, A. Pollington, C. Galea, S. Jaron, Y. Yamaguchi-Iwai, and J. Kaplan Inhibition of Heme Biosynthesis Prevents Transcription of Iron Uptake Genes in Yeast J. Biol. Chem., November 14, 2003; 278(46): 45499 - 45506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pastore, G. Tozzi, L. M. Gaeta, E. Bertini, V. Serafini, S. D. Cesare, V. Bonetto, F. Casoni, R. Carrozzo, G. Federici, et al. Actin Glutathionylation Increases in Fibroblasts of Patients with Friedreich's Ataxia: A POTENTIAL ROLE IN THE PATHOGENESIS OF THE DISEASE J. Biol. Chem., October 24, 2003; 278(43): 42588 - 42595. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tan, E. Napoli, F. Taroni, and G. Cortopassi Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells Hum. Mol. Genet., July 15, 2003; 12(14): 1699 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lesuisse, R. Santos, B. F. Matzanke, S. A. B. Knight, J.-M. Camadro, and A. Dancis Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1) Hum. Mol. Genet., April 15, 2003; 12(8): 879 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adinolfi, M. Trifuoggi, A. S. Politou, S. Martin, and A. Pastore A structural approach to understanding the iron-binding properties of phylogenetically different frataxins Hum. Mol. Genet., August 1, 2002; 11(16): 1865 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Karthikeyan, L. K. Lewis, and M. A. Resnick The mitochondrial protein frataxin prevents nuclear damage Hum. Mol. Genet., May 16, 2002; 11(11): 1351 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Becker, J. M. Greer, P. Ponka, and D. R. Richardson Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization Blood, May 15, 2002; 99(10): 3813 - 3822. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Tozzi, M Nuccetelli, M Lo Bello, S Bernardini, L Bellincampi, S Ballerini, L M Gaeta, C Casali, A Pastore, G Federici, et al. Antioxidant enzymes in blood of patients with Friedreich's ataxia Arch. Dis. Child., May 1, 2002; 86(5): 376 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cavadini, H. A. O'Neill, O. Benada, and G. Isaya Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia Hum. Mol. Genet., February 1, 2002; 11(3): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Melov, S. R. Doctrow, J. A. Schneider, J. Haberson, M. Patel, P. E. Coskun, K. Huffman, D. C. Wallace, and B. Malfroy Lifespan Extension and Rescue of Spongiform Encephalopathy in Superoxide Dismutase 2 Nullizygous Mice Treated with Superoxide Dismutase-Catalase Mimetics J. Neurosci., November 1, 2001; 21(21): 8348 - 8353. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Roy and N. C. Andrews Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers Hum. Mol. Genet., October 1, 2001; 10(20): 2181 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lodi, B. Rajagopalan, A. M Blamire, J.M. Cooper, C. H Davies, J. L Bradley, P. Styles, and A. H.V Schapira Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: An in vivo 31P magnetic resonance spectroscopy study Cardiovasc Res, October 1, 2001; 52(1): 111 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tan, L.-S. Chen, B. Lonnerdal, C. Gellera, F. A. Taroni, and G. A. Cortopassi Frataxin expression rescues mitochondrial dysfunctions in FRDA cells Hum. Mol. Genet., September 1, 2001; 10(19): 2099 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.W. Shults and A.H.V. Schapira A cue to queue for CoQ? Neurology, August 14, 2001; 57(3): 375 - 376. [Full Text] [PDF] |
||||
![]() |
P. Cavadini, C. Gellera, P. I. Patel, and G. Isaya Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae Hum. Mol. Genet., October 1, 2000; 9(17): 2523 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Puccio Recent advances in the molecular pathogenesis of Friedreich ataxia Hum. Mol. Genet., April 1, 2000; 9(6): 887 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dhe-Paganon, R. Shigeta, Y.-I. Chi, M. Ristow, and S. E. Shoelson Crystal Structure of Human Frataxin J. Biol. Chem., September 29, 2000; 275(40): 30753 - 30756. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cavadini, J. Adamec, F. Taroni, O. Gakh, and G. Isaya Two-step Processing of Human Frataxin by Mitochondrial Processing Peptidase. PRECURSOR AND INTERMEDIATE FORMS ARE CLEAVED AT DIFFERENT RATES J. Biol. Chem., December 22, 2000; 275(52): 41469 - 41475. [Abstract] [Full Text] [PDF] |
||||












